What is Royalty Pharma's total assets?

Royalty Pharma (RPRX) reported total assets of $19.82B in Q1 2026.

How has Royalty Pharma's total assets changed year-over-year?

Royalty Pharma's total assets increased by 12.5% year-over-year, from $17.61B to $19.82B.

What is the long-term trend for Royalty Pharma's total assets?

Over 5 years (2020 to 2025), Royalty Pharma's total assets has grown at a 4.1% compound annual growth rate (CAGR), from $16.02B to $19.62B.

What does total assets mean?

The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Royalty Pharma RPRX Total Assets

Total Assets at other companies

XOMA CorporationXOMA

$271.86M+27.8%

Ligand PharmaceuticalsLGND

$1.53B+69.2%

BridgeBio PharmaBBIO

$1.37B+55.5%

Rigel PharmaceuticalsRIGL

$504.61M+187%

Roivant SciencesROIV

$5.71B+5.0%

Ionis PharmaceuticalsIONS

$3.45B+22.6%

Other financials

Income statement

See full

Revenue$630.6M+11.0%

Operating income$563.0M+5.4%

Net income$294.7M+23.1%

EPS (diluted)$0.67+21.8%

Balance sheet

See full

Cash & equivalents$586.4M-46.1%

Total debt$9.0B+17.8%

Total equity$9.9B+1.6%

Cash flow

See full

Operating cash flow$718.2M+20.5%

Valuation

See full

Market cap$24.85B+72.3%

Enterprise value$33.24B+52.8%

P/E30×+15.9×

P/S10.2×+3.9×

Profitability

See full

Operating margin65.1%-18.9pp

Net margin33.9%-14.4pp

Returns & leverage

See full

Return on equity8.4%-2.7pp

Debt / equity0.9×+0.1×

Current ratio2.7×+1.1×

Where this comes from

Reported directly by Royalty Pharma in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Royalty Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Royalty Pharma's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Royalty Pharma's total assets?: Royalty Pharma (RPRX) reported total assets of $19.82B in Q1 2026.
How has Royalty Pharma's total assets changed year-over-year?: Royalty Pharma's total assets increased by 12.5% year-over-year, from $17.61B to $19.82B.
What is the long-term trend for Royalty Pharma's total assets?: Over 5 years (2020 to 2025), Royalty Pharma's total assets has grown at a 4.1% compound annual growth rate (CAGR), from $16.02B to $19.62B.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.